Open Access
MATEC Web of Conferences
Volume 60, 2016
2016 3rd International Conference on Chemical and Biological Sciences
Article Number 03002
Number of page(s) 5
Section Applied Chemistry
Published online 08 June 2016
  1. María L. Cuestas & Verónica L. Mathet. Drug delivery systems and liver targeting for improved pharmacotherapy of the Hepatitis B virus (HBV) infection. Pharm Res, 27, 1184–1202 (2010) [CrossRef]
  2. Su-zhen Jiang, Jia-jia Zheng. Hepatitis B Virus S Promoter Deletionin Hepatocellular Carcinoma. Infection Inte national, 1, 14-23 (2012)
  3. Hepatitis B. World Health Organization. World Health Org. 204 (2012)
  4. Park NH, Song IH. Chronic hepatitis B in hepatocarcinogenesis.Pos. Med J, 82(970), 507–515.(2006)
  5. Westland C, Delandy W. Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil.Gas, 125(1), 107-116 (2003) [CrossRef]
  6. Wright TL.Introduction to chronic hepatitis B infection.Am J Gastl, 101, 1-6 (2006) [CrossRef]
  7. Ceen-Ming Tang, Tung On Yau. Management of chronic hepatitis B infection: Currenttreatment guidelines, challenges, and new developmentsWorld J Gastroenterol, 20(20), 6262-6278 (2014) [CrossRef]
  8. Han YX, Xue R,Zhao W. Antiviral therapertic efficacy of foscamet inhepatitis B virus infection. Antiv Res, 68(3), 147-153 (2005) [CrossRef]
  9. Shin MS, Kang EH. A flavonoid from medicinal plants blocks hepatitis Bvirus-e antigen secretion in HBV-infected hepatocytes. Antiv Res, 67(3), 163–168 (2005) [CrossRef]
  10. Zembower DE, Lin YM. Robustaflavone, a potential non-nucleoside anti-hepatitis B agent. Antiv Res, 39(2),81-88 (1998) [CrossRef]
  11. Zhou Z,Zhang Y,Ding XR. Protocatechuic aldehyde inhibits hepatitis Bvirus replication both in vitro and in vivo. Antiv Res, 74(1), 59–64 (2007) [CrossRef]
  12. Addison WR, Wong WW. A quantitative competitive PCR assay for thecovalently closed circular form of the duck hepatitis B virus. Antiv Res, 48(l), 27-37 (2000) [CrossRef]
  13. Le Guerhier F, Thermet A. Antiviral effect of adefovir in combination with aDNA vaccine in the duck hepatitis B virus infection model.J. Hepa, 38(3), 328-334 (2003) [CrossRef]